96 related articles for article (PubMed ID: 11793090)
1. High serum levels of a non-(1-84) parathyroid hormone (PTH) fragment in pediatric haemodialysis patients.
Salomon R; Charbit M; Gagnadoux MF; Niaudet P; Gao P; Cantor T; Souberbielle JC
Pediatr Nephrol; 2001 Dec; 16(12):1011-4. PubMed ID: 11793090
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. [Intact whole bioactive parathormone: problems arising from comparing different methods].
Marangella M; Migliardi M; Dutto F; Mengozzi G; Marranca D; Bagnis C; Berutti S; Gallone G; Aimo G; Ramello A; Fonzo D
G Ital Nefrol; 2002; 19(4):467-75. PubMed ID: 12369051
[TBL] [Abstract][Full Text] [Related]
4. Multicenter evaluation of a new immunoassay for intact PTH measurement on the Elecsys System 2010 and 1010.
Hermsen D; Franzson L; Hoffmann JP; Isaksson A; Kaufman JM; Leary E; Müller C; Nakatsuka K; Nishizawa Y; Reinauer H; Riesen W; Roth HJ; Steinmüller T; Troch T; Bergmann P
Clin Lab; 2002; 48(3-4):131-41. PubMed ID: 11934215
[TBL] [Abstract][Full Text] [Related]
5. Influence of sevelamer hydrochloride on serum concentration of whole (1-84) and N-terminally truncated (7-84) parathyroid hormone fragments in hemodialysis uremic patients.
Chudek J; Piecha G; Kokot F; Wiecek A
J Nephrol; 2003; 16(5):710-5. PubMed ID: 14733418
[TBL] [Abstract][Full Text] [Related]
6. Influence of nutritional status on serum large N-truncated PTH, but not PTH(1-84) in hemodialysis patients.
Shidara K; Inaba M; Okuno S; Imanishi Y; Yamakawa T; Ishimura E; Kumeda Y; Nishizawa Y
Biomed Pharmacother; 2007; 61(2-3):142-7. PubMed ID: 17270383
[TBL] [Abstract][Full Text] [Related]
7. Very low or undetectable intact parathyroid hormone levels in patients with surgically verified parathyroid adenomas.
Bhadada SK; Cardenas M; Bhansali A; Mittal BR; Behera A; Chanukya GV; Nahar U; Rao DS
Clin Endocrinol (Oxf); 2008 Sep; 69(3):382-5. PubMed ID: 18284640
[TBL] [Abstract][Full Text] [Related]
8. Comparison between whole and intact parathyroid hormone assays.
Taniguchi M; Tanaka M; Hamano T; Nakanishi S; Fujii H; Kato H; Koiwa F; Ando R; Kimata N; Akiba T; Kono T; Yokoyama K; Shigematsu T; Kakuta T; Kazama JJ; Tominaga Y; Fukagawa M
Ther Apher Dial; 2011 Jun; 15 Suppl 1():42-9. PubMed ID: 21595852
[TBL] [Abstract][Full Text] [Related]
9. Immunoassays for the detection of parathyroid hormone.
Jüppner H; Potts JT
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N81-6. PubMed ID: 12412782
[TBL] [Abstract][Full Text] [Related]
10. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH.
Ueda M; Inaba M; Okuno S; Maeno Y; Ishimura E; Yamakawa T; Nishizawa Y
Life Sci; 2005 Jul; 77(10):1130-9. PubMed ID: 15978265
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of whole PTH assay and 1-84/non-(1-84) PTH ratio in patients on hemodialysis or undergoing parathyroidectomy.
Kato Y; Yamaguchi S; Yachiku S; Fujisawa M; Kawakami N
Hinyokika Kiyo; 2004 Nov; 50(11):755-62. PubMed ID: 15628534
[TBL] [Abstract][Full Text] [Related]
12. Bio-intact parathyroid hormone and intact parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism receiving intravenous calcitriol therapy.
Fujimori A; Sakai M; Yoshiya K; Shin J; Kim JI; Inaba Y; Miyamoto T; Inoue S; Fukagawa M
Ther Apher Dial; 2004 Dec; 8(6):474-9. PubMed ID: 15663547
[TBL] [Abstract][Full Text] [Related]
13. Parathyroid hormone control survey to determine inter-method and inter-lab variations in Japan.
Kakuta T; Kato H; Komaba H; Akizawa T;
Ther Apher Dial; 2011 Jun; 15 Suppl 1():50-5. PubMed ID: 21595853
[TBL] [Abstract][Full Text] [Related]
14. Effect of high-flux versus low-flux dialysis membranes on parathyroid hormone.
Makar SH; Sawires HK; Farid TM; Ali WM; Schaalan M
Iran J Kidney Dis; 2010 Oct; 4(4):327-32. PubMed ID: 20852376
[TBL] [Abstract][Full Text] [Related]
15. [Significance of serum PTH (7-84) as a reliable nutritional marker in hemodialysis patients].
Shidara K; Inaba M; Kumeda Y; Imanishi Y; Tahara H; Ishimura E; Nishizawa Y; Yamakawa T; Okuno S
Clin Calcium; 2005 Sep; 15 Suppl 1():102-4; discussion 104-5. PubMed ID: 16279018
[TBL] [Abstract][Full Text] [Related]
16. Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K/DOQI ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients.
Mazzaferro S; Pasquali M; Farcomeni A; Vestri AR; Filippini A; Romani AM; Barresi G; Pugliese F
Nephrol Dial Transplant; 2008 Jul; 23(7):2319-23. PubMed ID: 18281320
[TBL] [Abstract][Full Text] [Related]
17. High third generation/second generation PTH ratio in a patient with parathyroid carcinoma: clinical utility of third generation/second generation PTH ratio in patients with primary hyperparathyroidism.
Caron P; Maiza JC; Renaud C; Cormier C; Barres BH; Souberbielle JC
Clin Endocrinol (Oxf); 2009 Apr; 70(4):533-8. PubMed ID: 18782355
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of hypocalcemia with a highly sensitive, homologous radioimmunoassay for the midregion of parathyroid hormone.
Mallette LE; Wilson DP; Kirkland JL
Pediatrics; 1983 Jan; 71(1):64-9. PubMed ID: 6848981
[TBL] [Abstract][Full Text] [Related]
19. Third-generation parathyroid hormone assays and all-cause mortality in incident dialysis patients: the CHOICE study.
Melamed ML; Eustace JA; Plantinga LC; Jaar BG; Fink NE; Parekh RS; Coresh J; Yang Z; Cantor T; Powe NR
Nephrol Dial Transplant; 2008 May; 23(5):1650-8. PubMed ID: 18065788
[TBL] [Abstract][Full Text] [Related]
20. The influence of aluminium on parathyroid hormone levels in haemodialysis patients.
Cannata JB; Briggs JD; Junor BJ; Beastall G; Fell GS
Proc Eur Dial Transplant Assoc; 1983; 19():244-7. PubMed ID: 6878239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
